Skip to main content

Table 2 Description of parameters for combined models of pre- and post-treatment data

From: Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients

Model parameter

Description

 

β 0

Pre-treatment mean intercept

 

β 1

Pre-treatment mean slope

 

U 00

Pre-treatment intercept subject-specific random effect variance

 

ρ

Correlation between pre-treatment intercept and slope subject-specific random effects

 

U 11

Pre-treatment slope subject-specific random effect variance

 

σ

Standard deviation of residual error term for each measurement, shared by pre- and post-treatment parts of model

 

κ pre

Scale parameter for pre-treatment fBM process

 

H pre

Hurst index for pre-treatment fBM process

 

ϕ1 model

These parameters relate to the long-term maximum value of the response variable after treatment initiation

 

At11,At12

Intercept and slope terms in relationship with \(u_{i}^{+}\) for patients treated within 6 months of seroconversion

 

At21,At22

Intercept and slope terms in relationship with \(u_{i}^{+}\) for patients treated beyond 6 months but within 1 year of seroconversion

 

A1,A2

Intercept and slope terms in relationship with \(u_{i}^{+}\) for linear or NCS models a

 

A3,A4

Third and fourth coefficients for NCS models a

 

ϕ2 model

These parameters relate to the rate of recovery of the response variable after treatment initiation

 

Bt11,Bt12

Intercept and slope terms in relationship with \(u_{i}^{+}\) for patients treated within 6 months of seroconversion

 

Bt21,Bt22

Intercept and slope terms in relationship with \(u_{i}^{+}\) for patients treated beyond 6 months but within 1 year of seroconversion

 

B1,B2

Intercept and slope terms in relationship with \(u_{i}^{+}\) for linear or NCS models a

 

B3,B4

Third and fourth coefficients for NCS models a

 

P

Residual variance for long-term maximum (ϕ1:i) not explained by \(u_{i}^{+}\)

 

κ post

Scale parameter for post-treatment fBM process

 

H post

Hurst index for post-treatment fBM process

 

d f pre

Degrees of freedom parameter for pre-treatment stochastic process

 

d f post

Degrees of freedom parameter for post-treatment stochastic process

 

ρ Moran

Correlation parameter for latent scaling variables of pre- and post-treatment stochastic processes

 
  1. aOnly applicable to patients with treatment initiation more than 1year after seroconversion when separate terms are included for earlier groups. fBM, fractional Brownian motion; NCS, natural cubic spline Some of the parameters relate to the link functions between the ‘true’ value of the response variable at treatment initiation, \(u_{i}^{+}\), and the post-treatment model